Pancreatic lipase/Carboxylesterase 1-IN-1

• CAT Number: I043705
• CAS Number: 194235-21-7
• Molecular Formula: C30H44O4
• Molecular Weight: 468.67
• Purity: ≥95%
• Synonyms: (4aS,6aR,6aS,6bR,8aR,12aR,14bS)-11-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,6a,7,8,8a,13,14b-decahydro-1H-picene-4a-carboxylic acid
• InChI: InChI=1S/C30H44O4/c1-25(2)12-14-30(24(33)34)15-13-28(6)18(19(30)16-25)8-9-22-27(5)17-20(31)23(32)26(3,4)21(27)10-11-29(22,28)7/h8,17,19,21-22,31H,9-16H2,1-7H3,(H,33,34)/t19-,21-,22+,27-,28+,29+,30-/m0/s1
• InChIKey: OQLDDXDMTOPTDO-QRARIYCASA-N
• SMILES: C[C@@]12CC[C@@H]3[C@@]([C@H]1CC=C4[C@]2(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)C)(C=C(C(=O)C3(C)C)O)C

Pancreatic lipase/Carboxylesterase 1-IN-1（Cat No.:I043705）is a selective inhibitor targeting both pancreatic lipase and carboxylesterase 1 enzymes, which play crucial roles in lipid digestion and metabolism. By inhibiting these enzymes, it reduces the breakdown and absorption of dietary fats, potentially aiding in weight management and metabolic disorders. This dual-target approach also has implications in treating conditions like obesity and hyperlipidemia. Pancreatic lipase/Carboxylesterase 1-IN-1 is under investigation for its therapeutic potential in controlling fat digestion, reducing lipid accumulation, and improving metabolic health, particularly in disorders associated with dysregulated fat metabolism.